Undervalued Growth

BRFH remains undervalued relative to its growth profile, manufacturing transition, and potential EBITDA inflection. The company trades at a discount to both its historical trading range and relevant peers, despite a step‑change in revenue growth and a guided profitability inflection. Applying a 3.3x P/Sales multiple to BRFH’s 2026E revenue estimate implies an illustrative equity value of approximately $6.2 per share versus the current share price of $2.45.